Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Carboplatin, Paclitaxel and Hycamtin in Advanced Ovarian Cancer
NCT00003733Phase 2Unknown
- Sponsor
- GSK
- Start
- Dec 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan in ovarian cancer, sponsored by GSK. Status: unknown.
02
Drugs
topotecan
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00003733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003733.